Comparison

Oncology

Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.

The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.

To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.

 

Click on the organs and learn more about cancer types

´

General information

Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.

Relevant products for oncology research

1430 Item(s)

per page

Name PDF Type Clone Specific against Appl. Host Item no. Amount Price
hVEGF-­IN-­1 5mg Inhibitors Other A19518-5

Adooq
5 mg Login
Compare
hVEGF-­IN-­1 10mg Inhibitors Other A19518-10

Adooq
10 mg Login
Compare
hVEGF-­IN-­1 50mg Inhibitors Other A19518-50

Adooq
50 mg Login
Compare
ERK2 IN-­1 1mg Inhibitors Other A19533-1

Adooq
1 mg Login
Compare
ERK2 IN-­1 5mg Inhibitors Other A19533-5

Adooq
5 mg Login
Compare
ERK2 IN-­1 10mg Inhibitors Other A19533-10

Adooq
10 mg Login
Compare
Carbacyclin 1mg Inhibitors Other A19469-1

Adooq
1 mg Login
Compare
Carbacyclin 5mg Inhibitors Other A19469-5

Adooq
5 mg Login
Compare
Carbacyclin 10mg Inhibitors Other A19469-10

Adooq
10 mg Login
Compare
c-­Fms-­IN-­7 25mg Inhibitors Other A19407-25

Adooq
25 mg Login
Compare
c-­Fms-­IN-­7 50mg Inhibitors Other A19407-50

Adooq
50 mg Login
Compare
c-­Fms-­IN-­7 100mg Inhibitors Other A19407-100

Adooq
100 mg Login
Compare
c-­Fms-­IN-­6 25mg Inhibitors Other A19416-25

Adooq
25 mg Login
Compare
c-­Fms-­IN-­6 50mg Inhibitors Other A19416-50

Adooq
50 mg Login
Compare
c-­Fms-­IN-­6 100mg Inhibitors Other A19416-100

Adooq
100 mg Login
Compare
PI3K/­mTOR Inhibitor-­2 5mg Inhibitors Other A19621-5

Adooq
5 mg Login
Compare
PI3K/­mTOR Inhibitor-­2 100mg Inhibitors Other A19621-100

Adooq
100 mg Login
Compare
CHK1 inhibitor 1mg Inhibitors Other A19623-1

Adooq
1 mg Login
Compare
CHK1 inhibitor 5mg Inhibitors Other A19623-5

Adooq
5 mg Login
Compare
CHK1 inhibitor 10mg Inhibitors Other A19623-10

Adooq
10 mg Login
Compare
hVEGF-­IN-­1 25mg Inhibitors Other A19518-25

Adooq
25 mg Login
Compare
hVEGF-­IN-­1 100mg Inhibitors Other A19518-100

Adooq
100 mg Login
Compare
hVEGF-­IN-­1 200mg Inhibitors Other A19518-200

Adooq
200 mg Login
Compare
ERK2 IN-­1 50mg Inhibitors Other A19533-50

Adooq
50 mg Login
Compare
ERK2 IN-­1 100mg Inhibitors Other A19533-100

Adooq
100 mg Login
Compare
Name Price
hVEGF-­IN-­1 5mg Login
Type Inhibitors
Clone
Specific against Other
Appl.
Host
Item no.
Amount 5 mg
Available
hVEGF-­IN-­1 10mg Login
Type Inhibitors
Clone
Specific against Other
Appl.
Host
Item no.
Amount 10 mg
Available
hVEGF-­IN-­1 50mg Login
Type Inhibitors
Clone
Specific against Other
Appl.
Host
Item no.
Amount 50 mg
Available
ERK2 IN-­1 1mg Login
Type Inhibitors
Clone
Specific against Other
Appl.
Host
Item no.
Amount 1 mg
Available
ERK2 IN-­1 5mg Login
Type Inhibitors
Clone
Specific against Other
Appl.
Host
Item no.
Amount 5 mg
Available
ERK2 IN-­1 10mg Login
Type Inhibitors
Clone
Specific against Other
Appl.
Host
Item no.
Amount 10 mg
Available
Carbacyclin 1mg Login
Type Inhibitors
Clone
Specific against Other
Appl.
Host
Item no.
Amount 1 mg
Available
Carbacyclin 5mg Login
Type Inhibitors
Clone
Specific against Other
Appl.
Host
Item no.
Amount 5 mg
Available
Carbacyclin 10mg Login
Type Inhibitors
Clone
Specific against Other
Appl.
Host
Item no.
Amount 10 mg
Available
c-­Fms-­IN-­7 25mg Login
Type Inhibitors
Clone
Specific against Other
Appl.
Host
Item no.
Amount 25 mg
Available
c-­Fms-­IN-­7 50mg Login
Type Inhibitors
Clone
Specific against Other
Appl.
Host
Item no.
Amount 50 mg
Available
c-­Fms-­IN-­7 100mg Login
Type Inhibitors
Clone
Specific against Other
Appl.
Host
Item no.
Amount 100 mg
Available
c-­Fms-­IN-­6 25mg Login
Type Inhibitors
Clone
Specific against Other
Appl.
Host
Item no.
Amount 25 mg
Available
c-­Fms-­IN-­6 50mg Login
Type Inhibitors
Clone
Specific against Other
Appl.
Host
Item no.
Amount 50 mg
Available
c-­Fms-­IN-­6 100mg Login
Type Inhibitors
Clone
Specific against Other
Appl.
Host
Item no.
Amount 100 mg
Available
PI3K/­mTOR Inhibitor-­2 5mg Login
Type Inhibitors
Clone
Specific against Other
Appl.
Host
Item no.
Amount 5 mg
Available
PI3K/­mTOR Inhibitor-­2 100mg Login
Type Inhibitors
Clone
Specific against Other
Appl.
Host
Item no.
Amount 100 mg
Available
CHK1 inhibitor 1mg Login
Type Inhibitors
Clone
Specific against Other
Appl.
Host
Item no.
Amount 1 mg
Available
CHK1 inhibitor 5mg Login
Type Inhibitors
Clone
Specific against Other
Appl.
Host
Item no.
Amount 5 mg
Available
CHK1 inhibitor 10mg Login
Type Inhibitors
Clone
Specific against Other
Appl.
Host
Item no.
Amount 10 mg
Available
hVEGF-­IN-­1 25mg Login
Type Inhibitors
Clone
Specific against Other
Appl.
Host
Item no.
Amount 25 mg
Available
hVEGF-­IN-­1 100mg Login
Type Inhibitors
Clone
Specific against Other
Appl.
Host
Item no.
Amount 100 mg
Available
hVEGF-­IN-­1 200mg Login
Type Inhibitors
Clone
Specific against Other
Appl.
Host
Item no.
Amount 200 mg
Available
ERK2 IN-­1 50mg Login
Type Inhibitors
Clone
Specific against Other
Appl.
Host
Item no.
Amount 50 mg
Available
ERK2 IN-­1 100mg Login
Type Inhibitors
Clone
Specific against Other
Appl.
Host
Item no.
Amount 100 mg
Available

1430 Item(s)

per page